product summary
Loading...
company name :
Novus Biologicals
other brands :
IMGENEX
product type :
antibody
product name :
CD8 Antibody (YTS105.18) - BSA Free
catalog :
NB200-578
quantity :
0.125 mg
price :
409 USD
clonality :
monoclonal
host :
rat
conjugate :
nonconjugated
clone name :
YTS105.18
reactivity :
human, mouse
application :
immunohistochemistry, immunocytochemistry, flow cytometry, immunohistochemistry - paraffin section, immunohistochemistry - frozen section
more info or order :
citations: 21
Published Application/Species/Sample/DilutionReference
  • immunohistochemistry - frozen section; human; 1:100; loading ...; fig 5c
Wennerberg E, Mukherjee S, Spada S, Hung C, Agrusa C, Chen C, et al. Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non-small cell lung cancer. Sci Transl Med. 2022;14:eabe8195 pubmed publisher
Wilson A, Moffitt L, Doran B, Basri B, Do J, Jobling T, et al. Leader cells promote immunosuppression to drive ovarian cancer progression in vivo. Cell Rep. 2024;43:114979 pubmed publisher
Lin X, Zhang J, Liu Z, Wu D, Fang L, Li C, et al. Elevated FBXW10 drives hepatocellular carcinoma tumorigenesis via AR-VRK2 phosphorylation-dependent GAPDH ubiquitination in male transgenic mice. Cell Rep. 2023;42:112812 pubmed publisher
Wu Q, Huang Q, Jiang Y, Sun F, Liang B, Wang J, et al. Remodeling Chondroitin-6-Sulfate-Mediated Immune Exclusion Enhances Anti-PD-1 Response in Colorectal Cancer with Microsatellite Stability. Cancer Immunol Res. 2022;10:182-199 pubmed publisher
O Connor M, Kallenberg D, Camilli C, Pilotti C, Dritsoula A, Jackstadt R, et al. LRG1 destabilizes tumor vessels and restricts immunotherapeutic potency. Med (N Y). 2021;2:1231-1252.e10 pubmed publisher
Mealiea D, Boudreau E, de Silva N, Okamoto L, Ho T, Fish J, et al. Modeling oncolytic virus dynamics in the tumor microenvironment using zebrafish. Cancer Gene Ther. 2020;: pubmed publisher
Lourenco C, Kalkat M, Houlahan K, De Melo J, Longo J, Done S, et al. Modelling the MYC-driven normal-to-tumour switch in breast cancer. Dis Model Mech. 2019;12: pubmed publisher
Lima Fernandes E, Murison A, da Silva Medina T, Wang Y, Ma A, Leung C, et al. Targeting bivalency de-represses Indian Hedgehog and inhibits self-renewal of colorectal cancer-initiating cells. Nat Commun. 2019;10:1436 pubmed publisher
Kalkat M, Resetca D, Lourenco C, Chan P, Wei Y, Shiah Y, et al. MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis. Mol Cell. 2018;72:836-848.e7 pubmed publisher
Kato T, Jin C, Lee D, Ujiie H, Fujino K, Hu H, et al. Preclinical investigation of folate receptor-targeted nanoparticles for photodynamic therapy of malignant pleural mesothelioma. Int J Oncol. 2018;53:2034-2046 pubmed publisher
Priego N, Zhu L, Monteiro C, Mulders M, Wasilewski D, Bindeman W, et al. STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis. Nat Med. 2018;24:1024-1035 pubmed publisher
Kato T, Lee D, Huang H, Cruz W, Ujiie H, Fujino K, et al. Personalized siRNA-Nanoparticle Systemic Therapy using Metastatic Lymph Node Specimens Obtained with EBUS-TBNA in Lung Cancer. Mol Cancer Res. 2018;16:47-57 pubmed publisher
Ernsting M, Hoang B, Lohse I, Undzys E, Cao P, Do T, et al. Targeting of metastasis-promoting tumor-associated fibroblasts and modulation of pancreatic tumor-associated stroma with a carboxymethylcellulose-docetaxel nanoparticle. J Control Release. 2015;206:122-30 pubmed publisher
Tan Q, Joshua A, Saggar J, Yu M, Wang M, Kanga N, et al. Effect of pantoprazole to enhance activity of docetaxel against human tumour xenografts by inhibiting autophagy. Br J Cancer. 2015;112:832-40 pubmed publisher
. Sex-specific T-cell regulation of angiotensin II-dependent hypertension. Hypertension. 2014;64:573-82 pubmed publisher
Nakashima H, Terabe M, Berzofsky J, Husain S, Puri R. A novel combination immunotherapy for cancer by IL-13Rα2-targeted DNA vaccine and immunotoxin in murine tumor models. J Immunol. 2011;187:4935-46 pubmed publisher
Lacroix Lamandé S, Rochereau N, Mancassola R, Barrier M, Clauzon A, Laurent F. Neonate intestinal immune response to CpG oligodeoxynucleotide stimulation. PLoS ONE. 2009;4:e8291 pubmed publisher
Karlsson M, Johansen F, Kahu H, MacPherson A, Brandtzaeg P. Hypersensitivity and oral tolerance in the absence of a secretory immune system. Allergy. 2010;65:561-70 pubmed publisher
Auray G, Lacroix Lamandé S, Mancassola R, Dimier Poisson I, Laurent F. Involvement of intestinal epithelial cells in dendritic cell recruitment during C. parvum infection. Microbes Infect. 2007;9:574-82 pubmed
Himoudi N, Nabarro S, Yan M, Gilmour K, Thrasher A, Anderson J. Development of anti-PAX3 immune responses; a target for cancer immunotherapy. Cancer Immunol Immunother. 2007;56:1381-95 pubmed
Sroga J, Jones T, Kigerl K, McGaughy V, Popovich P. Rats and mice exhibit distinct inflammatory reactions after spinal cord injury. J Comp Neurol. 2003;462:223-40 pubmed
product information
master code :
NB200-578
SKU :
NB200-578
product name :
CD8 Antibody (YTS105.18) - BSA Free
unit size :
0.125 mg
description :
The CD8 Antibody (YTS105.18) - BSA Free from Novus is a rat monoclonal antibody to CD8. This antibody reacts with human,mouse. The CD8 Antibody (YTS105.18) - BSA Free has been validated for the following applications: IF/IHC,Immunohistochemistry-Paraffin,Flow Cytometry,Immunohistochemistry,Immunohistochemistry-Frozen,Immunohistochemistry-Paraffin (Negative).
target :
CD8
category :
Primary Antibodies
buffer :
PBS
clonality :
Monoclonal
clone :
YTS105.18
concentration :
1.0 mg/ml
conjugate :
Unconjugated
host :
Rat
immunogen :
Mouse spleen cells
isotype :
IgG2a
purity :
Protein G purified
species :
Human,Mouse
specificity :
CD8 Antibody (YTS105
theoretical molecular weight :
26 kDa
gene symbol :
CD8A
accessionNumbers :
P01731, P01731
applications :
IF/IHC,Immunohistochemistry-Paraffin,Flow Cytometry,Immunohistochemistry,Immunohistochemistry-Frozen,Immunohistochemistry-Paraffin (Negative)
USD :
409 USD
alt names :
CD_antigen: CD8a, CD8, CD8 antigen, alpha polypeptide (p32), CD8A, CD8a molecule, LEU2, Leu2 T-lymphocyte antigen, MAL, OKT8 T-cell antigen, p32, T cell co-receptor, T8 T-cell antigen, T-cell antigen Leu2, T-cell surface glycoprotein CD8 alpha chain, T-lymphocyte differentiation antigen T8/Leu-2
storage :
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
more info or order :
company information
Novus Biologicals
10771 E Easter Ave
Centennial, CO 80112
novus@novusbio.com
https://www.novusbio.com
3037301950
headquarters: USA
Novus Biologicals licenses, manufactures, and markets antibodies to over 20,000 unique targets to support a wide array of research areas. Novus is built on honesty, collaboration and strong relationships and continues to provide quality tools that accelerate research. Every product is backed by our 100% guarantee.